Quarterly Statement of Operations Information (Unaudited)

12 Months Ended

Sep. 26, 2020

Quarterly Financial Information Disclosure [Abstract]

Quarterly Statement of Operations Information (Unaudited)

Quarterly Statement of Operations Information (Unaudited)

The following table presents a summary of quarterly results of operations for fiscal 2020 and 2019:

	2020
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Total revenue	$	850.5	$	756.1	$	822.9	$	1,347.0
Gross profit	433.8		395.8		466.1		931.8
Net income attributable to Hologic (1)	386.1		96.3		137.9		495.0
Diluted net income per common share	$	1.43	$	0.36	$	0.53	$	1.88

	2019
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Total revenue	$	830.7	$	818.4	$	852.4	$	865.8
Gross profit	$	434.1	$	42.4	$	444.8	$	249.5
Net income (loss) (2)	$	98.6	$	(272.6)	$	93.9	$	(123.5)
Diluted net income (loss) per common share	$	0.36	$	(1.01)	$	0.35	$	(0.46)

(1)Net income in the first quarter of fiscal 2020 included an intangible assets and equipment charge of $30.2 million due to classifying the Medical Aesthetics business as assets held-for-sale. Net income also included a discrete tax benefit related to the disposition of this business of $312.2 million related to its outside basis difference.

(2)Net loss in the second quarter of fiscal 2019 included intangible asset and equipment impairment charges of $443.8 million. Net loss in the fourth quarter of fiscal 2019 included intangible asset and equipment impairment charges of $241.6 million.